Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advitech, a health sciences and technology company, has signed an exclusive collaboration agreement with Laboratories Urgo, a provider of wound care products, band-aids and adhesive dressings.
Subscribe to our email newsletter
The partnership focuses on the technological platforms IM and XP-828L developed by Advitech, which have demonstrated in in-vitro and in-vivo preclinical studies the dual ability to accelerate the wound healing process and to control the remodeling of collagen. Both partners view these abilities as a unique property when compared to existing products.
Additionally, this partnership entails the implementation of a reciprocal collaboration process on current Advitech’s research program encompassing the two platforms and the negotiation of a development or a co-development agreement to take place by mid-2009.
Urgo has also validated the preclinical results obtained by Advitech, its R&D program on wound healing and the potential of Advitech’s platforms to generate commercial applications in the field of wound healing.
Renaud Beauchesne, president and CEO of Advitech, said: “An agreement with a key player such as Urgo in the wound healing area is an important milestone of Advitech’s 2008 plan. We are proud of this new step and partnership with Urgo which, we believe, demonstrate the ability of our technological platforms to deliver new solutions.”